Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Director departure
Quarterly results
Appointed director
Cardiff Oncology, Inc. (TROV) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/26/2023 8-K Investor presentation
Docs: "Pancreatic Cancer and Small Cell Lung Cancer Program Updates Metastatic Pancreatic Ductal Adenocarcinoma",
"Cardiff Oncology Announces Positive Clinical Data in Pancreatic Cancer and Small Cell Lung Cancer, including Single-Agent Activity from Onvansertib Monotherapy Pancreatic Cancer Program"
08/07/2023 8-K Investor presentation
Docs: "Investor Contact:"
01/18/2022 8-K Investor presentation
Docs: "Cardiff Oncology Announces New Data from Lead Clinical Program in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival",
"Mark Erlander, Ph.D. Chief Executive Officer 20222021 2008 2013 2017 20222021 2008 2013 2017"
09/08/2021 8-K Quarterly results
06/01/2021 8-K Quarterly results
04/12/2021 8-K Quarterly results
09/21/2020 8-K Investor presentation
Docs: "Company Presentation"
01/13/2020 8-K Investor presentation
Docs: "Company Presentation"
07/15/2019 8-K Investor presentation
Docs: "Trovagene Commences Non-Deal Investor Roadshow",
"Company Presentation"
07/17/2018 8-K Investor presentation
Docs: "Trovagene, Inc. Corporate Presentation"
01/08/2018 8-K Investor presentation
Docs: "Trovagene, Inc. Corporate Presentation"
11/28/2017 8-K Investor presentation
Docs: "Trovagene, Inc. Corporate Presentation"
09/21/2017 8-K Quarterly results
08/21/2017 8-K Quarterly results
05/01/2017 8-K Form 8-K - Current report
03/28/2017 8-K Form 8-K - Current report
01/09/2017 8-K Form 8-K - Current report
09/26/2016 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
07/11/2016 8-K Form 8-K - Current report
01/13/2016 8-K/A Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
01/11/2016 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
11/16/2015 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
07/06/2015 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
05/19/2015 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
02/05/2015 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation",
"Trovagene, Inc. Company Presentation",
"Trovagene, Inc. Announces Public Offering of Common Stock",
"Trovagene, Inc. Announces Public Offering of Common Stock"
10/02/2014 8-K Investor presentation
Docs: "Trovagene, Inc. Corporate Presentation"
06/02/2014 8-K Investor presentation
Docs: "Trovagene, Inc. Corporate Presentation",
"Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response"
04/14/2014 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
02/10/2014 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
01/13/2014 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
10/22/2013 8-K Form 8-K - Current report
07/23/2013 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
06/26/2013 8-K Form 8-K - Current report
04/22/2013 8-K Investor presentation
Docs: "Trovagene, Inc. Company Presentation"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy